Show items per page
Elements: 8
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies Frisoni, Giovanni; Molinuevo, José Luis; Altomare, Daniele; Carrera, Emmanuel; ... Ritchie, Craig 2020
add to browser selection
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset Altomare, Daniele; Ferrari, Clarissa; Caroli, Anna; Galluzzi, Samantha; ... Frisoni, Giovanni 2019
add to browser selection
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study van Maurik, Ingrid S; Vos, Stephanie J; Bos, Isabelle; Bouwman, Femke H; ... van der Flier, Wiesje M 2019
add to browser selection
Applying the ATN scheme in a memory clinic population: The ABIDE project Altomare, Daniele; de Wilde, Arno; Ossenkoppele, Rik; Pelkmans, Wiesje; ... van der Flier, Wiesje M 2019
add to browser selection
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype Vermunt, Lisa; Sikkes, Sietske A M; van den Hout, Ardo; Handels, Ron; ... Visser, Pieter Jelle 2019
add to browser selection
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression Caroli, Anna; Prestia, Annapaola; Galluzzi, Samantha; Ferrari, Clarissa; ... Frisoni, Giovanni 2015
add to browser selection
SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease Ramirez, Alfredo; van der Flier, Wiesje M; Herold, Christine; Ramonet, David 2014
add to browser selection
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease Prestia, Annapaola; Caroli, Anna; van der Flier, Wiesje M; Ossenkoppele, Rik; ... Frisoni, Giovanni 2013